Showing results (1-10 of 1,829) with videos related to

Sort By:
Pageof 183
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or olderR A Popescu, A Norman, P J Ross, et al.
British Journal of Cancer|April 17, 1999
Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinomaL Assersohn, A Norman, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2002
Baseline quality of life predicts survival in patients with advanced colorectal cancerN R Maisey, A Norman, M Watson, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Surgery plus chemotherapy or chemotherapy alone for primary intermediate- and high-grade gastric non-Hodgkin's lymphoma: the Royal Marsden Hospital experienceR A Popescu, A C Wotherspoon, D Cunningham, et al.
Pathology Oncology Research : POR|July 9, 1998
Chemotherapy of oesophago-gastric cancerP J Ross, S Rao, D Cunningham
British Journal of Cancer|July 22, 2004
Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancerS Rao, D Cunningham, T Price, et al.
British Journal of Cancer|April 28, 2005
Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancerS Rao, D Cunningham, R E Hawkins, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?N R Maisey, M E Hill, A Webb, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 11, 2004
Chemotherapy for primary gastric lymphoma: does in-patient observation prevent complications?N Maisey, A Norman, Y Prior, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagusJ S Waters, D Tait, D Cunningham, et al.
Pageof 183